These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33846210)

  • 1. Overcoming spectrum bias for accurate SARS-CoV-2 seroprevalence estimates.
    Puhan MA; Chiolero A; Fehr J; Cullati S;
    BMJ; 2021 Apr; 373():n917. PubMed ID: 33846210
    [No Abstract]   [Full Text] [Related]  

  • 2. Dried Blood Spot as an Alternative to Plasma/Serum for SARS-CoV-2 IgG Detection, an Opportunity to Be Sized to Facilitate COVID-19 Surveillance Among Schoolchildren.
    Amendola A; Bianchi S; Gori M; Barcellini L; Colzani D; Canuti M; Giacomet V; Fabiano V; Folgori L; Zuccotti GV; Tanzi E
    Pediatr Infect Dis J; 2021 Jan; 40(1):e46-e47. PubMed ID: 33181785
    [No Abstract]   [Full Text] [Related]  

  • 3. Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients.
    Del Zompo F; De Maio F; Santopaolo F; Ricci R; Gasbarrini A; Pompili M; Ponziani FR
    Dig Liver Dis; 2021 May; 53(5):541-544. PubMed ID: 33707148
    [No Abstract]   [Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
    Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
    Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
    Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers.
    Hasan T; Lim HL; Hueston L; Dwyer DE; O'Sullivan M
    Pathology; 2021 Dec; 53(7):917-919. PubMed ID: 34635322
    [No Abstract]   [Full Text] [Related]  

  • 8. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust.
    Grant JJ; Wilmore SMS; McCann NS; Donnelly O; Lai RWL; Kinsella MJ; Rochford HL; Patel T; Kelsey MC; Andrews JA
    Infect Control Hosp Epidemiol; 2021 Feb; 42(2):212-214. PubMed ID: 32746953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Seropositivity among US Marine Recruits Attending Basic Training, United States, Spring-Fall 2020.
    Letizia AG; Ge Y; Goforth CW; Weir DL; Lizewski R; Lizewski S; Soares-Schanoski A; Vangeti S; Marjanovic N; Sealfon SC; Ramos I
    Emerg Infect Dis; 2021 Apr; 27(4):1188-1192. PubMed ID: 33529569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of the SARS-CoV-2 antigen detection test in nasopharyngeal swab for COVID-19 infection control].
    Folgueira López MD
    Rev Esp Quimioter; 2020 Dec; 33(6):390-391. PubMed ID: 33231027
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
    Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
    J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches.
    Bouman JA; Riou J; Bonhoeffer S; Regoes RR
    PLoS Comput Biol; 2021 Feb; 17(2):e1008728. PubMed ID: 33635863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years - Mississippi, May-September 2020.
    Hobbs CV; Drobeniuc J; Kittle T; Williams J; Byers P; Satheshkumar PS; Inagaki K; Stephenson M; Kim SS; Patel MM; Flannery B;
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(9):312-315. PubMed ID: 33661862
    [No Abstract]   [Full Text] [Related]  

  • 15. Greater public health impact of COVID-19 antigen detection tests.
    Kowada A
    BMC Med; 2021 Mar; 19(1):82. PubMed ID: 33757504
    [No Abstract]   [Full Text] [Related]  

  • 16. SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis.
    Berardis S; Verroken A; Vetillart A; Struyf C; Gilbert M; Gruson D; Gohy S
    J Cyst Fibros; 2020 Nov; 19(6):872-874. PubMed ID: 32828701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital.
    Lapić I; Rogić D; Šegulja D; Kralik Oguić S; Knežević J
    Croat Med J; 2020 Dec; 61(6):485-490. PubMed ID: 33410294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications.
    Jiang JC; Zhang Y
    Biochem Soc Trans; 2020 Dec; 48(6):2851-2863. PubMed ID: 33170924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of SARS-CoV-2 antibody assays evaluated in Auckland, New Zealand.
    Fox-Lewis S; Whitcombe A; McGregor R; Carlton L; Hwang Y; Austin P; Aspin L; Raill B; Webb R; Taylor S; Morpeth S; Roberts S; Moreland NJ; McAuliffe G
    N Z Med J; 2020 Nov; 133(1525):127-131. PubMed ID: 33223557
    [No Abstract]   [Full Text] [Related]  

  • 20. Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA.
    Thomas SN; Altawallbeh G; Zaun CP; Pape KA; Peters JM; Titcombe PJ; Dileepan T; Rapp MJ; Bold TD; Schacker TW; Arbefeville S; Ferrieri P; Thyagarajan B; Jenkins MK; Karger AB
    Clin Biochem; 2021 Apr; 90():15-22. PubMed ID: 33539808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.